Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	167.89	964.90	-360.19
Graham Fair Price	-12.06	8.99	10.23
PEG	-76.80	1.00	4.30
Price/Book	-27.64	4.15	5.74
Price/Cash Flow	-84.15	67.35	424.86
Prices/Earnings	10.22	-20.32	-22.64
Price/Sales	-26.09	18.90	25.57
Price/FCF	-84.15	67.35	424.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	31.37	0.85	0.64
Operating Margin	87.49	-0.04	-0.29
ROA	20.94	-0.01	-0.02
ROE	-0.06	-0.05	19.40
ROIC	-0.02	< 0.005	87.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.10	-93.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.18	0.88	393.10
EPS QOQ	0.05	0.20	287.04
FCF QOQ	-0.44	3.54	712.85
Revenue QOQ	0.19	-0.03	-86.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-0.01	-426.61	-3433011.74
Days Sales Outstanding (DSO)	804.51	45.85	-94.30
Inventory Turnover	-7242.62	-0.21	100.00
Debt/Capitalization	0.70	0.70	0.08
Quick Ratio	45.59	14.54	-68.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	8.57	8.39	-2.04
Cash	6.34	6.93	9.29
Capex	-0.13	-0.15	-18.01
Free Cash Flow	0.12	0.52	347.13
Revenue	1.92	1.84	-4.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	48.83	14.54	-70.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-92.29	289.33	213.50
Naive Interpretation	Member

06 - Financial Health · Bad

Rating